BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27349943)

  • 1. Meta-analysis of alkaline phosphatase and prognosis for osteosarcoma.
    Hao H; Chen L; Huang D; Ge J; Qiu Y; Hao L
    Eur J Cancer Care (Engl); 2017 Sep; 26(5):. PubMed ID: 27349943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does serum alkaline phosphatase level really indicate the prognosis in patients with osteosarcoma? A meta-analysis.
    Gu R; Sun Y
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S468-S472. PubMed ID: 29970708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of serum lactate dehydrogenase and prognosis for osteosarcoma.
    Fu Y; Lan T; Cai H; Lu A; Yu W
    Medicine (Baltimore); 2018 May; 97(19):e0741. PubMed ID: 29742740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Significance of Serum Alkaline Phosphatase Level in Osteosarcoma: A Meta-Analysis of Published Data.
    Ren HY; Sun LL; Li HY; Ye ZM
    Biomed Res Int; 2015; 2015():160835. PubMed ID: 26618165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High serum alkaline phosphatase cooperating with MMP-9 predicts metastasis and poor prognosis in patients with primary osteosarcoma in Southern China.
    Han J; Yong B; Luo C; Tan P; Peng T; Shen J
    World J Surg Oncol; 2012 Feb; 10():37. PubMed ID: 22333159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of long non-coding RNA TUG1 correlates with poor prognosis and disease status in osteosarcoma.
    Ma B; Li M; Zhang L; Huang M; Lei JB; Fu GH; Liu CX; Lai QW; Chen QQ; Wang YL
    Tumour Biol; 2016 Apr; 37(4):4445-55. PubMed ID: 26499949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of prognostic factors in osteosarcoma adult patients, a single institution experience].
    Adamkova Krakorova D; Vesely K; Zambo I; Tucek S; Tomasek J; Jureckova A; Janicek P; Cerny J; Pazourek L; Ondrusek S; Selingerova I
    Klin Onkol; 2012; 25(5):346-58. PubMed ID: 23102196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of vascular endothelial growth factor expression on overall survival in patients with osteosarcoma: a meta-analysis.
    Zhuang Y; Wei M
    Tumour Biol; 2014 Mar; 35(3):1745-9. PubMed ID: 24515658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prognostic Role of Ezrin Immunoexpression in Osteosarcoma: A Meta-Analysis of Published Data.
    Li H; Min D; Zhao H; Wang Z; Qi W; Zheng S; Tang L; He A; Sun Y; Yao Y; Shen Z
    PLoS One; 2013; 8(6):e64513. PubMed ID: 23805177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of ifosfamide-based chemotherapy for osteosarcoma: a meta-analysis.
    Fan XL; Cai GP; Zhu LL; Ding GM
    Drug Des Devel Ther; 2015; 9():5925-32. PubMed ID: 26604690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
    Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
    PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic role of pathologic fracture in osteosarcoma: Evidence based on 1,677 subjects.
    Yang M
    J Cancer Res Ther; 2015; 11(2):264-7. PubMed ID: 26148581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of serum lactate dehydrogenase level in osteosarcoma: a meta-analysis.
    Chen J; Sun MX; Hua YQ; Cai ZD
    J Cancer Res Clin Oncol; 2014 Jul; 140(7):1205-10. PubMed ID: 24682390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surrogate endpoints for overall survival in randomised controlled trials of localised osteosarcoma: A meta-analytic evaluation.
    Tanaka K; Kawano M; Iwasaki T; Matsuda S; Itonaga I; Tsumura H
    Sci Rep; 2020 May; 10(1):8573. PubMed ID: 32444660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between the expression of Ki-67 and the prognosis of osteosarcoma.
    Zeng M; Zhou J; Wen L; Zhu Y; Luo Y; Wang W
    BMC Cancer; 2021 Mar; 21(1):210. PubMed ID: 33648449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Albumin-to-alkaline phosphatase ratio as a promising indicator of prognosis in human cancers: is it possible?
    An L; Yin WT; Sun DW
    BMC Cancer; 2021 Mar; 21(1):247. PubMed ID: 33685425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reassessment of alkaline phosphatase as serum tumor marker with high specificity in osteosarcoma.
    Kim SH; Shin KH; Moon SH; Jang J; Kim HS; Suh JS; Yang WI
    Cancer Med; 2017 Jun; 6(6):1311-1322. PubMed ID: 28493412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a pretreatment prognostic index to predict death and lung metastases in extremity osteosarcoma.
    Wang B; Tu J; Yin J; Zou C; Wang J; Huang G; Xie X; Shen J
    Oncotarget; 2015 Nov; 6(35):38348-59. PubMed ID: 26435480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of serum alkaline phosphatase in the survival of prostate cancer: evidence from a meta-analysis.
    Li D; Lv H; Hao X; Hu B; Song Y
    Cancer Manag Res; 2018; 10():3125-3139. PubMed ID: 30214305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive expression of non-bone/liver/kidney alkaline phosphatase in human osteosarcoma cell lines.
    Ali NN; Rowe J; Teich NM
    J Bone Miner Res; 1996 Apr; 11(4):512-20. PubMed ID: 8992882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.